antibody Archives – Cambridge Enterprise

Immutrin raises £65 million Series A to develop next generation antibody therapy for ATTR amyloidosis

26 March 2026 • 4 min read

XO1 crystal structure

Spin-out X01 acquired by Janssen

07 April 2015 • 2 min read

X01: towards the ‘holy grail’ of anticoagulant drugs

17 June 2013 • 3 min read

Pfizer extends field of use for Cambridge-developed antibody engineering technology

07 June 2010 • 1 min read